← Leaderboards
Ahmara G. Ross
University Of Pennsylvania
$2,315,164
Attributed
$2,315,164
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,315,164 · 2
By mechanism
R56$1,357,192 · 1
K08$957,972 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Eric A Pierce$25,662,965
- James R McKay$19,797,907
- Wafik S El-Deiry$15,004,115
- William A. Beltran$14,525,140
- Jerry D Glickson$20,468,757
Others in their field
Other Emerging Leaders on “Physiologic Intraocular Pressure”
- Balasubramani K Goundappa · University Of Pittsburgh At Pittsburgh$8,538,627
- Krishnakumar Kizhatil · Columbia University Health Sciences$4,080,371
- Ayellet Vered Segre · Massachusetts Eye And Ear Infirmary$3,794,243
- Anthony Realini · West Virginia University$3,061,147
- Daniel Sun · Schepens Eye Research Institute$3,021,750
- Hua Liu · University Of Texas Med Br Galveston$3,015,399
Research focus
Physiologic Intraocular PressureCellsInduced Pluripotent Stem CellPhenotypeRetinal Ganglion CellsLeadGenesGlaucomaMolecularPathway InteractionsViral VectorVisualOverexpressionMouse ModelAdeno-Associated Viral VectorCell SurvivalBlindGene TherapyBiogenesisBaseCharacteristicsAmericanAwarenessCellular Stress
Grant awards (6)
The Impact of WDR36 Variants and p53 in Glaucoma$1,357,192
R56 · FY2025 · EY · contact PI
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic Glaucoma$227,037
K08 · FY2022 · EY · contact PI
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic Glaucoma$227,037
K08 · FY2021 · EY · contact PI
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic Glaucoma$227,125
K08 · FY2020 · EY · contact PI
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic Glaucoma$49,648
K08 · FY2020 · EY · contact PI
The Development of Gene Therapy Using SIRT1 Signaling to Treat Chronic Glaucoma$227,125
K08 · FY2019 · EY · contact PI